Phase II multicenter study of antroquinonol in patients with stage IV non-small cell lung cancer who have failed at least two lines of anti-cancer therapy.

Authors

Bradley Lash MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2019

Volume

37

Issue

15

Published In/Presented At

https://doi.org/10.1200/JCO.2019.37.15_suppl.e2052

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division

Document Type

Article